On Monday, Tribune Publishing's board adopted a shareholder rights plan to defend itself against Gannett's unsolicited bid. The so-called poison pill approach would kick in if a group buys more than 20 percent of Tribune Publishing's shares, making a sale of the company more expensive and effectively preventing Gannett from going directly to Tribune Publishing shareholders with a tender offer, forcing negotiations to run through the board.